Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 12-2010 | 06-2010 | 12-2009 | 06-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 4,830 | N/A | 750 | N/A |
| Receivables | N/A | 0 | N/A | 140 | N/A |
| Other current assets | 0 | 1,310 | 0 | 1,490 | 0 |
| TOTAL | $N/A | $6,140 | $N/A | $2,380 | $N/A |
| Non-Current Assets | |||||
| PPE Net | N/A | 5 | N/A | 6 | N/A |
| Other Non-Current Assets | 0 | 4,767 | 0 | 4,297 | 0 |
| TOTAL | $N/A | $4,772 | $N/A | $4,303 | $N/A |
| Total Assets | $N/A | $10,910 | $N/A | $6,690 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 620 | 0 | 990 | 0 |
| Accrued Expenses | N/A | 370 | N/A | 450 | N/A |
| Other current liabilities | N/A | 4 | N/A | 0 | N/A |
| TOTAL | $N/A | $3,190 | $N/A | $1,500 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 1,000 | 0 | 970 | 0 |
| TOTAL | $N/A | $1,000 | $N/A | $970 | $N/A |
| Total Liabilities | $N/A | $4,190 | $N/A | $2,470 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | N/A | 690 | N/A | 280 | N/A |
| Retained earnings | N/A | -55,670 | N/A | -33,110 | N/A |
| Other shareholders' equity | 0 | -10 | 0 | 0 | 0 |
| TOTAL | $N/A | $6,710 | $N/A | $4,210 | $N/A |
| Total Liabilities And Equity | $0 | $10,900 | $0 | $6,680 | $0 |